David Gordon, MB ChB
2018
In 2018, David Gordon, MB ChB earned a total compensation of $2.1M as Chief Medical Officer at Aclaris Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $67,896 |
|---|---|
| Option Awards | $1,334,760 |
| Salary | $244,444 |
| Stock Awards | $468,720 |
| Other | $358 |
| Total | $2,116,178 |
ChB received $1.3M in option awards, accounting for 63% of the total pay in 2018.
ChB also received $67.9K in non-equity incentive plan, $244.4K in salary, $468.7K in stock awards and $358 in other compensation.
Rankings
In 2018, David Gordon, MB ChB's compensation ranked 5,437th out of 14,244 executives tracked by ExecPay. In other words, ChB earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,437 out of 14,244 | 62nd |
Division Manufacturing | 2,051 out of 5,765 | 64th |
Major group Chemicals And Allied Products | 749 out of 2,128 | 65th |
Industry group Drugs | 629 out of 1,817 | 65th |
Industry Pharmaceutical Preparations | 484 out of 1,391 | 65th |
Source: SEC filing on April 25, 2019.
ChB's colleagues
We found two more compensation records of executives who worked with David Gordon, MB ChB at Aclaris Therapeutics in 2018.